Stemchymal

· Steminent US, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Stemchymal, covering 2022-10-27 to 2024-05-02. Get the full timeline:

Most recent: Clinical Trial Update: Stemchymal® for Polyglutamine Spinocerebellar Ataxia [Phase 2]